Quantitative muscle ultrasonography in the follow-up of juvenile dermatomyositis

Muscle and Nerve

Volumn 52, Issue 4, 2015, Pages 540-546

  Habers, G Esther A ^a   Van Brussel, Marco ^a   Bhansing, Kavish J ^b   Hoppenreijs, Esther P ^b   Janssen, Anjo J W M ^b   Van Royen Kerkhof, Annet ^a   Pillen, Sigrid ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Echo intensity; Follow up; Juvenile dermatomyositis; Muscle thickness; Quantitative muscle ultrasonography

Indexed keywords

CREATINE KINASE; IMMUNOGLOBULIN; METHOTREXATE; METHYLPREDNISOLONE; PREDNISONE; RITUXIMAB;

ARTICLE; CHILD; CHILDHOOD MYOSITIS ASSESSMENT SCALE; CLINICAL ARTICLE; DISEASE SEVERITY; ECHOGRAPHY; FEMALE; FOLLOW UP; HUMAN; JUVENILE DERMATOMYOSITIS; MALE; MINIMAL RESIDUAL DISEASE; MULTIPLE CYCLE TREATMENT; MUSCLE ATROPHY; MUSCLE FATIGUE; MUSCLE INJURY; MUSCLE STRENGTH; MUSCLE THICKNESS; MYOFIBROSIS; PRESCHOOL CHILD; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RATING SCALE; REAL TIME ULTRASOUND SCANNER; SCHOOL CHILD; ADOLESCENT; BLOOD; DERMATOMYOSITIS; ENDURANCE; INFANT; MOTOR ACTIVITY; NEWBORN; PATHOPHYSIOLOGY; PHYSIOLOGY; RETROSPECTIVE STUDY; SEVERITY OF ILLNESS INDEX; SKELETAL MUSCLE;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; CREATINE KINASE; DERMATOMYOSITIS; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; MALE; MOTOR ACTIVITY; MUSCLE STRENGTH; MUSCLE, SKELETAL; PHYSICAL ENDURANCE; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX;

EID: 84942194959     PISSN: 0148639X     EISSN: 10974598     Source Type: Journal    
DOI: 10.1002/mus.24564     Document Type: Article

References (39)

1. Feldman BM, Rider LG, Reed AM, Pachman LM. Juvenile dermatomyositis and other idiopathic inflammatory myopathies of childhood. Lancet 2008;371:2201-2212.
2. Loell I, Lundberg IE. Can muscle regeneration fail in chronic inflammation: a weakness in inflammatory myopathies? J Intern Med 2011;269:243-257.
3. Takken T, Elst EF, van der Net J. Pathophysiological factors which determine the exercise intolerance in patients with juvenile dermatomyositis. Curr Rheumatol Rev 2005;1:91-99.
4. Rider LG, Katz JD, Jones OY. Developments in the classification and treatment of the juvenile idiopathic inflammatory myopathies. Rheum Dis Clin North Am 2013;39:877-904.
5. Huber AM, Feldman BM, Rennebohm RM, Hicks JE, Lindsley CB, Perez MD, et al. Validation and clinical significance of the Childhood Myositis Assessment Scale for assessment of muscle function in the juvenile idiopathic inflammatory myopathies. Arthritis Rheum 2004;50:1595-1603.
6. Lovell DJ, Lindsley CB, Rennebohm RM, Ballinger SH, Bowyer SL, Giannini EH, et al. Development of validated disease activity and damage indices for the juvenile idiopathic inflammatory myopathies. II. The Childhood Myositis Assessment Scale (CMAS): a quantitative tool for the evaluation of muscle function. The Juvenile Dermatomyositis Disease Activity Collaborative Study Group. Arthritis Rheum 1999;42:2213-2219.
7. Luca NJ, Feldman BM. Disease activity measures in paediatric rheumatic diseases. Int J Rheumatol 2013;2013:715352.
8. Ruperto N, Ravelli A, Pistorio A, Ferriani V, Calvo I, Ganser G, et al. The provisional Paediatric Rheumatology International Trials Organisation/American College of Rheumatology/European League Against Rheumatism Disease activity core set for the evaluation of response to therapy in juvenile dermatomyositis: a prospective validation study. Arthritis Rheum 2008;59:4-13.
9. Rider LG, Werth VP, Huber AM, Alexanderson H, Rao AP, Ruperto N, et al. Measures of adult and juvenile dermatomyositis, polymyositis, and inclusion body myositis: Physician and Patient/Parent Global Activity, Manual Muscle Testing (MMT), Health Assessment Questionnaire (HAQ)/Childhood Health Assessment Questionnaire (C-HAQ), Childhood Myositis Assessment Scale (CMAS), Myositis Disease Activity Assessment Tool (MDAAT), Disease Activity Score (DAS), Short Form 36 (SF-36), Child Health Questionnaire (CHQ), physician global damage, Myositis Damage Index (MDI), Quantitative Muscle Testing (QMT), Myositis Functional Index-2 (FI-2), Myositis Activities Profile (MAP), Inclusion Body Myositis Functional Rating Scale (IBMFRS), Cutaneous Dermatomyositis Disease Area and Severity Index (CDASI), Cutaneous Assessment Tool (CAT), Dermatomyositis Skin Severity Index (DSSI), Skindex, and Dermatology Life Quality Index (DLQI). Arthritis Care Res (Hoboken) 2011;63(Suppl 11):S118-S157.
10. Del Grande F, Carrino JA, Del Grande F, Mammen AL, Christopher SL. Magnetic resonance imaging of inflammatory myopathies. Top Magn Reson Imaging 2011;22:39-43.
11. Malattia C, Damasio MB, Madeo A, Pistorio A, Providenti A, Pederzoli S, et al. Whole-body MRI in the assessment of disease activity in juvenile dermatomyositis. Ann Rheum Dis 2014;73:1083-1090.
12. Tomasova SJ, Charvat F, Jarosova K, Vencovsky J. The role of MRI in the assessment of polymyositis and dermatomyositis. Rheumatology (Oxford) 2007;46:1174-1179.
13. Pillen S, Arts IM, Zwarts MJ. Muscle ultrasound in neuromuscular disorders. Muscle Nerve 2008;37:679-693.
14. Zaidman CM, Connolly AM, Malkus EC, Florence JM, Pestronk A. Quantitative ultrasound using backscatter analysis in Duchenne and Becker muscular dystrophy. Neuromuscul Disord 2010;20:805-809.
15. Janssen BH, Pillen S, Voet NB, Heerschap A, van Engelen BG, van Alfen N. Quantitative muscle ultrasound versus quantitative MRI in facioscapulohumeral dystrophy. Muscle Nerve 2014;50:968-975.
16. Arts IM, Schelhaas HJ, Verrijp KC, Zwarts MJ, Overeem S, van der Laak JA, et al. Intramuscular fibrous tissue determines muscle echo intensity in amyotrophic lateral sclerosis. Muscle Nerve 2012;45:449-450.
17. Pillen S, Tak RO, Zwarts MJ, Lammens MM, Verrijp KN, Arts IM, et al. Skeletal muscle ultrasound: correlation between fibrous tissue and echo intensity. Ultrasound Med Biol 2009;35:443-446.
18. Reimers K, Reimers CD, Wagner S, Paetzke I, Pongratz DE. Skeletal muscle sonography: a correlative study of echogenicity and morphology. J Ultrasound Med 1993;12:73-77.
19. Mayans D, Cartwright MS, Walker FO. Neuromuscular ultrasonography: quantifying muscle and nerve measurements. Phys Med Rehabil Clin N Am 2012;23:133-148, xii.
20. Jansen M, van Alfen N, Nijhuis van der Sanden MW, van Dijk JP, Pillen S, de Groot IJ. Quantitative muscle ultrasound is a promising longitudinal follow-up tool in Duchenne muscular dystrophy. Neuromuscul Disord 2012;22:306-317.
21. Mittal GA, Wadhwani R, Shroff M, Sukthankar R, Pathan E, Joshi VR. Ultrasonography in the diagnosis and follow-up of idiopathic inflammatory myopathies-a preliminary study. J Assoc Physicians India 2003;51:252-256.
22. Bhansing K, Hoppenreijs E, Janssen A, van Royen-Kerkhof A, Nijhuis-Van der SM, van Riel P, et al. Quantitative muscle ultrasound: a potential tool for assessment of disease activity in juvenile dermatomyositis. Scand J Rheumatol 2014;43:339-341.
23. Bohan A, Peter JB. Polymyositis and dermatomyositis (second of two parts). N Engl J Med 1975;292:403-407.
24. Bohan A, Peter JB. Polymyositis and dermatomyositis (first of two parts). N Engl J Med 1975;292:344-347.
25. Stringer E, Singh-Grewal D, Feldman BM. Predicting the course of juvenile dermatomyositis: significance of early clinical and laboratory features. Arthritis Rheum 2008;58:3585-3592.
26. Franck PFH, Spaans A, Postma J. Het Nederlandse Referentieloboratorium voor Enzymen. Ned Tijdschr Klin Chem Labgeneesk 2010;35:240-243.
27. Miller FW, Rider LG, Chung YL, Cooper R, Danko K, Farewell V, et al. Proposed preliminary core set measures for disease outcome assessment in adult and juvenile idiopathic inflammatory myopathies. Rheumatology (Oxford) 2001;40:1262-1273.
28. Scholten RR, Pillen S, Verrips A, Zwarts MJ. Quantitative ultrasonography of skeletal muscles in children: normal values. Muscle Nerve 2003;27:693-698.
29. Pillen S, van Dijk JP, Weijers G, Raijmann W, de Korte CL, Zwarts MJ. Quantitative gray-scale analysis in skeletal muscle ultrasound: a comparison study of two ultrasound devices. Muscle Nerve 2009;39:781-786.
30. Pillen S, Verrips A, van Alfen N, Arts IM, Sie LT, Zwarts MJ. Quantitative skeletal muscle ultrasound: diagnostic value in childhood neuromuscular disease. Neuromuscul Disord 2007;17:509-516.
31. Zaidman CM, Wu JS, Wilder S, Darras BT, Rutkove SB. Minimal training is required to reliably perform quantitative ultrasound of muscle. Muscle Nerve 2014;50:124-128.
32. Weber MA. Ultrasound in the inflammatory myopathies. Ann N Y Acad Sci 2009;1154:159-170.
33. Gonzalez-Izal M, Lusa CE, Izquierdo M. Muscle conduction velocity, surface electromyography variables, and echo intensity during concentric and eccentric fatigue. Muscle Nerve 2014;49:389-397.
34. Adler RS, Garofalo G. Ultrasound in the evaluation of the inflammatory myopathies. Curr Rheumatol Rep 2009;11:302-308.
35. Hernandez RJ, Sullivan DB, Chenevert TL, Keim DR. MR imaging in children with dermatomyositis: musculoskeletal findings and correlation with clinical and laboratory findings. AJR Am J Roentgenol 1993;161:359-366.
36. Huppertz HI, Kaiser WA. Serial magnetic resonance imaging in juvenile dermatomyositis-delayed normalization. Rheumatol Int 1994;14:127-129.
37. Mathiesen P, Hegaard H, Herlin T, Zak M, Pedersen FK, Nielsen S. Long-term outcome in patients with juvenile dermatomyositis: a cross-sectional follow-up study. Scand J Rheumatol 2012;41:50-58.
38. Mathiesen PR, Orngreen MC, Vissing J, Andersen LB, Herlin T, Nielsen S. Aerobic fitness after JDM-a long-term follow-up study. Rheumatology (Oxford) 2013;52:287-295.
39. Takken T, van der Net J, Engelbert RH, Pater S, Helders PJ. Responsiveness of exercise parameters in children with inflammatory myositis. Arthritis Rheum 2008;59:59-64.